Regulation (EEC) No 1768/92 – Medicinal products – Supplementary protection certificate – Certificate of negative duration

Request for an Advisory Opinion from the EFTA Court by the Supreme Court of Iceland (Hæstiréttur Íslands), received on 15 June 2017 in the case of Merck Sharp & Dohme Corp. v the Icelandic Patent Office (Einkaleyfastofan)

22/06/17 - Deadline for written observations from Governments and relevant institutions (cf. Article 20 of the Statute): Tuesday, 22 August 2017

15/08/17 - Written observations received from the Icelandic Patent Office

21/08/17 - Written observations received from the Government of Norway

22/08/17 - Written observations received from the European Commission

22/08/17 - Written observations received from Merck Sharp & Dohme Corp.

22/08/17 - Written observations received from the EFTA Surveillance Authority

25/08/17 - Service of the written observations